Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).

Petros D GrivasY LoriotR Morales-BarreraM Y TeoY ZakhariaS FeyerabendN J VogelzangE GrandeN AdraA AlvaA NecchiA Rodriguez-VidaS GuptaD H JosephsS SrinivasK WrideD ThomasA SimmonsA LoehrR L DusekD NepertS Chowdhury

Published in: BMC cancer (2021)

This trial was registered in ClinicalTrials.gov (NCT03397394). Date of registration: 12 January 2018. This trial was registered in EudraCT (2017-004166-10).

Keyphrases

phase iii
phase ii
open label
study protocol
clinical trial
squamous cell carcinoma
locally advanced
small cell lung cancer
randomized controlled trial
lymph node
placebo controlled